Lista de obras -

Advances in first-line treatment for patients with HER-2+ metastatic breast cancer

artículo científico publicado en 2012

Are acinic cell carcinomas of the breast and salivary glands distinct diseases?

artículo científico publicado en 2015

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors

artículo científico

Brain metastasis: new opportunities to tackle therapeutic resistance

artículo científico publicado en 2014

Breast cancer and HSP90 inhibitors: is there a role beyond the HER2-positive subtype?

artículo científico publicado en 2012

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion

artículo científico publicado en 2018

Cancer as an ecomolecular disease and a neoplastic consortium

artículo científico publicado en 2017

Cell-free circulating tumour DNA as a liquid biopsy in breast cancer

artículo científico publicado en 2015

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

artículo científico

Circulating tumour cells in early breast cancer

Clinical implications of intratumor heterogeneity: challenges and opportunities

artículo científico publicado en 2020

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

artículo científico publicado en 2014

Development of molecular biomarkers in individualized treatment of colorectal cancer

artículo científico publicado en 2011

Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing

artículo científico publicado en 2013

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper

artículo científico

Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast

scientific article published on 26 June 2014

Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers

artículo científico publicado en 2017

Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluid.

artículo científico publicado en 2017

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

artículo científico publicado en 2015

New emerging targets in cancer immunotherapy: the role of neoantigens

artículo científico publicado en 2020

News from ASCO 2018

artículo científico publicado en 2018

PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come

scientific article published on 01 August 2020

Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection

artículo científico publicado en 2013

Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer

artículo científico publicado en 2011

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study

artículo científico publicado en 2012

The Genomic Landscape of Male Breast Cancers

artículo científico publicado en 2016

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

artículo científico publicado en 2019

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

scientific article published on 19 December 2018

The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study

artículo científico publicado en 2015

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers

artículo científico publicado en 2021

Translating neoadjuvant therapy into survival benefits: one size does not fit all.

artículo científico publicado en 2016

Use of pertuzumab for the treatment of HER2-positive metastatic breast cancer

artículo científico publicado en 2013

Lista de obras de

Advances in first-line treatment for patients with HER-2+ metastatic breast cancer

Are acinic cell carcinomas of the breast and salivary glands distinct diseases?

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors

Brain metastasis: new opportunities to tackle therapeutic resistance

Breast cancer and HSP90 inhibitors: is there a role beyond the HER2-positive subtype?

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion

Cancer as an ecomolecular disease and a neoplastic consortium

Cell-free circulating tumour DNA as a liquid biopsy in breast cancer

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

Circulating tumour cells in early breast cancer

Clinical implications of intratumor heterogeneity: challenges and opportunities

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

Development of molecular biomarkers in individualized treatment of colorectal cancer

Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper

Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast

Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers

Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluid.

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

New emerging targets in cancer immunotherapy: the role of neoantigens

News from ASCO 2018

PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come

Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection

Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study

The Genomic Landscape of Male Breast Cancers

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers

Translating neoadjuvant therapy into survival benefits: one size does not fit all.

Use of pertuzumab for the treatment of HER2-positive metastatic breast cancer